Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate

被引:0
|
作者
Espinet, Blanca [1 ,3 ]
Carla Oliveira, Ana [2 ]
Boque, Concepcion [2 ]
Domingo, Alicia [2 ]
Alonso, Esther [2 ]
Sole, Francesc [1 ,3 ]
机构
[1] Hosp del Mar, Lab Citogenet & Biol Mol, Serv Patol, IMAS,URNHE PRBB, Barcelona, Spain
[2] Hosp Univ Bellvitge, Serv Hematol, ICO, Barcelona, Spain
[3] Escola Citol Hematol Soledad Woessner IMAS, Barcelona, Spain
关键词
chronic myeloid leukemia; clonal cytogenetic abnormalities; imatinib;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The emergence of clonal chromosomal abnormalities in Philadelphia-negative cells during treatment with imatinib in patients with Philadelphia-positive chronic myeloid leukemia has been reported. We add information to this issue presenting a series of 29 patients in complete cytogenetic response after imatinib treatment, three of whom developed clonal aberrations.
引用
收藏
页码:556 / 558
页数:4
相关论文
共 50 条
  • [41] Patients with chronic myeloid leukemia treated with imatinib who showed the appearance of clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells
    da Rocha, M. M.
    Otero, L.
    Padilha, T. F.
    Dobbin, J.
    de Souza Fernandez, C.
    Abdelhay, E.
    de Souza Fernandez, T.
    BLOOD CANCER JOURNAL, 2011, 1 : e45 - e45
  • [42] Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia - Author reply
    Kantarjian, HM
    Cortes, J
    CANCER, 2003, 98 (08) : 1777 - 1778
  • [43] Patients with chronic myeloid leukemia treated with imatinib who showed the appearance of clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells
    M M da Rocha
    L Otero
    T F Padilha
    J Dobbin
    C de Souza Fernandez
    E Abdelhay
    T de Souza Fernandez
    Blood Cancer Journal, 2011, 1 : e45 - e45
  • [44] Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia
    Khan, Khurshid Ahmed
    Junaid, Ayesha
    Siddiqui, Nauman Saleem
    Mukhtar, Khalida
    Siddiqui, Saleem
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2008, 18 (03): : 176 - 178
  • [45] Very late relapse in a patient with chronic myeloid leukemia in sustained complete cytogenetic response under imatinib
    Defina, M.
    Gozzetti, A.
    Rondoni, M.
    Aprile, L.
    Ippoliti, M.
    Chitarrelli, I.
    Lauria, F.
    Bocchia, M.
    LEUKEMIA RESEARCH, 2010, 34 (08) : E215 - E216
  • [46] Impact of Imatinib Adherence on the Cytogenetic Response in Pediatric Chronic Myeloid Leukemia - Chronic Phase
    Ranga Raman Ganta
    Srividya Nasaka
    Sadashivudu Gundeti
    The Indian Journal of Pediatrics, 2016, 83 : 1009 - 1012
  • [47] Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases
    L Fayad
    H Kantarjian
    S O’Brien
    D Seong
    M Albitar
    M Keating
    M Talpaz
    Leukemia, 1997, 11 : 767 - 771
  • [48] Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: Report of three cases
    Fayad, L
    Kantarjian, H
    OBrien, S
    Seong, D
    Albitar, M
    Keating, M
    Talpaz, M
    LEUKEMIA, 1997, 11 (05) : 767 - 771
  • [49] LONG TERM OUTCOME AND CYTOGENETIC RESPONSE WITH IMATINIB IN CHILDHOOD CHRONIC MYELOID LEUKEMIA
    Bansal, Deepak
    Varma, Neelam
    Trehan, Amita
    Marwaha, R. K.
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 866 - 867
  • [50] Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.
    Kantarjian, H
    Sawyers, C
    Hochhaus, A
    Guilhot, F
    Schiffer, C
    Gambacorti-Passerini, C
    Niederwieser, D
    Resta, D
    Capdeville, R
    Zoellner, U
    Talpaz, M
    Druker, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09): : 645 - 652